- Home
- SA vs SPRY Comparison
SA vs SPRY Comparison
Compare SA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SA
- SPRY
- Stock Information
- Founded
- SA 1979
- SPRY 2015
- Country
- SA Canada
- SPRY United States
- Employees
- SA N/A
- SPRY N/A
- Industry
- SA Precious Metals
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- SA Basic Materials
- SPRY Health Care
- Exchange
- SA Nasdaq
- SPRY Nasdaq
- Market Cap
- SA 1.1B
- SPRY 1.1B
- IPO Year
- SA N/A
- SPRY N/A
- Fundamental
- Price
- SA $11.90
- SPRY $12.57
- Analyst Decision
- SA
- SPRY Strong Buy
- Analyst Count
- SA 0
- SPRY 4
- Target Price
- SA N/A
- SPRY $26.00
- AVG Volume (30 Days)
- SA 615.6K
- SPRY 1.5M
- Earning Date
- SA 11-14-2024
- SPRY 11-13-2024
- Dividend Yield
- SA N/A
- SPRY N/A
- EPS Growth
- SA N/A
- SPRY N/A
- EPS
- SA N/A
- SPRY N/A
- Revenue
- SA N/A
- SPRY $2,568,000.00
- Revenue This Year
- SA N/A
- SPRY $66,750.00
- Revenue Next Year
- SA N/A
- SPRY $508.63
- P/E Ratio
- SA N/A
- SPRY N/A
- Revenue Growth
- SA N/A
- SPRY 8460.00
- 52 Week Low
- SA $9.31
- SPRY $6.00
- 52 Week High
- SA $20.55
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- SA 41.83
- SPRY 58.86
- Support Level
- SA $11.56
- SPRY $11.00
- Resistance Level
- SA $12.33
- SPRY $12.48
- Average True Range (ATR)
- SA 0.41
- SPRY 0.81
- MACD
- SA 0.15
- SPRY 0.28
- Stochastic Oscillator
- SA 70.55
- SPRY 84.95
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.